Rutgers has granted Tonix Pharmaceutical exclusive worldwide rights to develop and commercialize a novel class of compounds ...
April M. Kloxin, professor of chemical and biomolecular engineering and materials science and engineering at the University of Delaware, has been named director of the Delaware Biotechnology Institute ...
IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of ...
Inocras, a bioinformatics-led company harnessing the power of whole genome data and proprietary analytics to deliver curated insights, today announced that Accent Therapeutics will deploy Inocras’ ...
Five Nigerian private universities had offered scholarships and financial aid, providing tuition support for students based ...
In today's digital-first world, data is not just information--it is insight, strategy, and competitive advantage. From healthcare and finance to e-commerce and artificial intelligence, organisations ...
Inocras, a bioinformatics-led company harnessing the power of whole genome data and proprietary analytics to deliver curated insights, today announced that Accent Therapeutics will deploy Inocras' ...
News Medical on MSN
Study offers a practical strategy to enhance effectiveness of immune checkpoint inhibitors
Cancer immunotherapy has transformed modern oncology by harnessing body's own immune system to combat malignant disease.
AstraZeneca's Dr. Sophie Kirschner to present data demonstrating how biomodal's 6--base sequencing solution enhances the sensitivity of liquid biopsy ...
LIGAND-AI is a flagship project of the Target 2035 initiative, funded by the Innovative Health Initiative, a public-private partnership (PPP) between the European Union and the European life science ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results